RAD51D and breast cancer: For several candidate genes, potentially pathogenic variants were enriched in a specific phenotypic sub-cohort, despite not showing evidence of an association with BC in the overall case-control cohort, including the suggested associations for ERCC5, RAD51D, MUTYH, MRE11A and TLDC1 with TN BC.